Multi-Centre UK Analysis of Simultaneous Pancreas and Kidney (SPK) Transplant in Recipients With Type 2 Diabetes Mellitus
Transplant International · 2024
DOI: 10.3389/ti.2023.11792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2024. Verfasst von Ruth V Owen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne, United Kingdom. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Pancreas Transplantation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
90% of the UK diabetic population are classified as T2DM. This study aims to compare outcomes after SPK transplant between recipients with T1DM or T2DM. Data on all UK SPK transplants from 2003–2019 were obtained from the NHSBT Registry ( n = 2,236). Current SPK transplant selection criteria for T2DM requires insulin treatment and recipient BMI < 30 kg/m 2 . After exclusions (re-transplants/ambiguous type of diabetes) we had a cohort of n = 2,154. Graft (GS) and patient (PS) survival analyses were conducted using Kaplan-Meier plots and Cox-regression models. Complications were compared using chi-squared analyses. 95.6% of SPK transplants were performed in recipients with T1DM ( n = 2,060). Univariate analysis showed comparable outcomes for pancreas GS at 1 year ( p = 0.120), 3 years ( p = 0.237), and 10 years ( p = 0.196) and kidney GS at 1 year ( p = 0.438), 3 years ( p = 0.548), and 10 years ( p = 0.947). PS was comparable at 1 year ( p = 0.886) and 3 years ( p = 0.237) and at 10 years ( p = 0.161). Multi-variate analysis showed comparable outcomes in pancreas GS ( p = 0.564, HR 1.221, 95% CI 0.619, 2.406) and PS( p = 0.556, HR 1.280, 95% CI 0.563, 2.911). Comparable rates of common complications were demonstrated. This is the largest series outside of the US evaluating outcomes after SPK transplants and shows similar outcomes between T1DM and T2DM recipients. It is hoped dissemination of this data will lead to increased referral rates and assessment of T2DM patients who could benefit from SPK transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne, United Kingdom.
- John Radcliffe Hospital, Oxford, United Kingdom.
- Statistics and Clinical Research, NHS Blood and Transplant, Bristol, United Kingdom.
- Blood and Transplant Unit, Newcastle University, Newcastle Upon Tyne, United Kingdom.
Zitieren
APA
Owen, R. V., Carr, H. J., Counter, C., Tingle, S. J., Thompson, E. R., Manas, D. M., Shaw, J. A., Wilson, C. H., & White, S. A. (2024). Multi-Centre UK Analysis of Simultaneous Pancreas and Kidney (SPK) Transplant in Recipients With Type 2 Diabetes Mellitus. Transplant International. https://doi.org/10.3389/ti.2023.11792
Vancouver
Owen RV, Carr HJ, Counter C, Tingle SJ, Thompson ER, Manas DM, et al. Multi-Centre UK Analysis of Simultaneous Pancreas and Kidney (SPK) Transplant in Recipients With Type 2 Diabetes Mellitus. Transplant International. 2024. doi:10.3389/ti.2023.11792
BibTeX
@article{Owen2024,
author = {Owen, Ruth V and Carr, Harry J and Counter, Claire and Tingle, Samuel J and Thompson, Emily R and Manas, Derek M and Shaw, James A and Wilson, Colin H and White, Steve A},
title = {Multi-Centre UK Analysis of Simultaneous Pancreas and Kidney (SPK) Transplant in Recipients With Type 2 Diabetes Mellitus},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2023.11792}
}
EUVIMED